Managing Potassium in Patients With Heart Failure
Why potassium monitoring remains central to safe, effective heart failure treatment.
Why potassium monitoring remains central to safe, effective heart failure treatment.
Practical clinical guidance for the considered use of MRA therapy in HFrEF.
Putting blood pressure into the wider context of treatment decisions in HFrEF.
A focused discussion of endocrine tolerability considerations in MRA therapy.
Why timely MRA initiation deserves a place in the clinical conversation for patients with HFrEF.
A practical reflection on when and how heart failure treatment may need to be reviewed, reduced or interrupted.
Expert perspective on maintaining evidence-based HFrEF care when low blood pressure complicates treatment decisions.
Summary of study: The study aimed to investigate the outcomes, healthcare patterns, and costs related to suspected de novo heart failure (patients experiencing it for the first time). Patients were selected based on presenting with signs or symptoms of HF.…